Can a phone app tame asthma? UK pilot study tests digital platform

NCT ID NCT06364527

Completed Disease control Sponsor: CoheroHealth Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This pilot study tested a digital health platform that combines a smartphone app and connected inhaler sensors to help people with asthma track their medication use and technique. 94 adults with uncontrolled moderate-to-severe asthma in the UK used the platform for 6 months. The goal was to see if the tool could improve asthma control and quality of life, and help patients communicate better with their healthcare providers.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Aptar Digital Health respiratory disease management platform (a smartphone app and healthcare provider portal used with connected inhaler sensors)
What this could lead to: If successful, this digital tool could help people with asthma better manage their condition and improve communication with their doctors.
What could go wrong: This is a small pilot study with no control group, so results may not be conclusive. The platform depends on users consistently engaging with the app and sensors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

asthma chronic asthma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ASTHMA CHRONIC

Contacts and locations

Locations

Guy's and St. Thomas' NHS Foundation Trust

London, England, SE1 9RT, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.